{
  "meta": {
    "title": "4_Hmp_Shunt_Pathway_Fructose_Galactose_Metabolism",
    "url": "https://brainandscalpel.vercel.app/4-hmp-shunt-pathway-fructose-galactose-metabolism-6112f961.html",
    "scrapedAt": "2025-11-30T12:26:46.611Z"
  },
  "questions": [
    {
      "text": "Which of the following is false about HMP shunt pathway?",
      "choices": [
        {
          "id": 1,
          "text": "No ATP formation"
        },
        {
          "id": 2,
          "text": "Formation of NADPH occurs"
        },
        {
          "id": 3,
          "text": "Synthesis of ribose-5-phosphate occurs"
        },
        {
          "id": 4,
          "text": "Non-oxidative phase is irreversible"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>non-oxidative phase</strong> of the HMP pathway is <strong>reversible.</strong></p>\n<p>In the HMP shunt, no ATP is formed, but the formation of NADPH and ribose takes place. The pentose phosphate pathway is an alternative route for the metabolism of glucose.</p>\n<p>It does not lead to the formation of ATP, but it has two major functions:</p>\n<ul>\n<li>Main source of <strong>NADPH: </strong>important for reductive biosynthesis of fatty acids and steroids, and maintaining reduced glutathione for antioxidant activity</li>\n<li>Synthesis of <strong>ribose-5-phosphate </strong></li>\n</ul>\n<p>There are 2 phases in the HMP pathway:</p>\n<ul>\n<li>Oxidative: irreversible</li>\n<li>Non-oxidative: reversible</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d30fa5e80b044cb38b5f599291fe732fx1280x2140.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Phases of HMP Shunt and the Enzymes Involved</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phases</strong></p>\n</td>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Irreversible oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Glucose-6-phosphate dehydrogenase</p>\n<p>6-Phosphogluconate dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reversible non-oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>3-Epimerase or Keto-isomerase</p>\n<p>Transketolase</p>\n<p>Transaldolase</p>\n<p>Phosphohexose isomerase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1864",
      "difficulty": "easy"
    },
    {
      "text": "In which of the following sites does HMP shunt occur?",
      "choices": [
        {
          "id": 1,
          "text": "Golgi apparatus"
        },
        {
          "id": 2,
          "text": "Mitochondria"
        },
        {
          "id": 3,
          "text": "Endoplasmic reticulum"
        },
        {
          "id": 4,
          "text": "Cytosol"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>HMP shunt </strong>takes place in the <strong>cytosol </strong>as enzymes needed for the HMP shunt (pentose phosphate) pathway are located in the cytoplasm.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1865",
      "difficulty": "medium"
    },
    {
      "text": "HMP shunt can occur at all of the following sites except:",
      "choices": [
        {
          "id": 1,
          "text": "Liver"
        },
        {
          "id": 2,
          "text": "Adipose tissue"
        },
        {
          "id": 3,
          "text": "Adrenal cortex"
        },
        {
          "id": 4,
          "text": "Muscles"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>HMP shunt pathway can not occur in <strong>muscles</strong> because muscle tissue is <strong>deficient</strong> in <strong>glucose 6-phosphate dehydrogenase,</strong> the rate-limiting enzyme in the oxidative phase of the pathway.</p>\n<p><strong>HMP shunt pathway</strong> takes place in the following:</p>\n<ul>\n<li>Liver</li>\n<li>Adipose tissue</li>\n<li>Adrenal cortex</li>\n<li>Thyroid</li>\n<li>Erythrocytes</li>\n<li>Testis</li>\n<li>Lactating mammary glands</li>\n</ul>\n<p>Given below is the HMP shunt pathway.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fbaa89c1b18f4ac8a3c11019fa6b174cx1279x2140.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1866",
      "difficulty": "medium"
    },
    {
      "text": "NADPH is used in ______.",
      "choices": [
        {
          "id": 1,
          "text": "Fatty acid synthesis"
        },
        {
          "id": 2,
          "text": "Ketone synthesis"
        },
        {
          "id": 3,
          "text": "Gluconeogenesis"
        },
        {
          "id": 4,
          "text": "Glycolysis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>NADPH </strong>is the source of reducing equivalent for<strong> fatty acid synthesis</strong>.</p>\n<p> This NADPH is derived from 3 sources:</p>\n<ul>\n<li>HMP shunt pathway (main source)</li>\n<li>Extramitochondrial isocitrate dehydrogenase (minor source)</li>\n<li>Malic enzyme</li>\n</ul><hr><h3>Related Pearl: Reducing Equivalents and Their Uses</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Reducing agents</p>\n</td>\n<td>\n<p>Uses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADPH</p>\n</td>\n<td>\n<p>Lipid synthesis</p>\n<p>Cholesterol synthesis&nbsp;</p>\n<p>Fatty acid chain elongation</p>\n<p>Cytochrome P450&nbsp;hydroxylation&nbsp;of&nbsp;aromatic compounds, steroids,&nbsp;alcohols, and&nbsp;drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADH</p>\n</td>\n<td>\n<p>Metabolizes alcohol</p>\n<p>Glycolysis &amp; Krebs cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>&beta;- Oxidation of fatty acid</p>\n<p>Catalyzes reactions in muscle and liver cells</p>\n<p>Electron Transport Chain</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FADH<sub>2</sub></p>\n</td>\n<td>\n<p>Krebs cycle</p>\n<p>Electron Transport Chain</p>\n<p>Oxidative Phosphorylation</p>\n<p>Cytochrome P450 hydroxylase cycle</p>\n<p>&beta;-Oxidation of fatty acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7395",
      "difficulty": "medium"
    },
    {
      "text": "A young man with chronic bacterial prostatitis was treated with cotrimoxazole. During treatment, he developed malaise, jaundice, abdominal pain, and dark urine. His blood picture is given below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hemolytic uremic syndrome"
        },
        {
          "id": 2,
          "text": "Autoimmune hemolytic anemia"
        },
        {
          "id": 3,
          "text": "Paroxysmal nocturnal hemoglobinuria"
        },
        {
          "id": 4,
          "text": "Glucose 6 phosphate dehydrogenase deficiency"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most likely diagnosis in the above case scenario is glucose-6-phosphate dehydrogenase <strong>(G6PD) deficiency.</strong></p>\n<p>The clinical features are suggestive of an <strong>acute hemolytic reaction</strong> following the administration of <strong>cotrimoxazole</strong>. A hemolytic attack starts with abrupt onset of malaise, weakness, and abdominal or lumbar pain. After an interval of several hours to 2–3 days, the patient develops jaundice and often dark urine, due to hemoglobinuria. </p>\n<p>The peripheral smear shows characteristic <strong>\"bite cells\"</strong> or <strong>degmacytes</strong> or <strong>blister cells</strong>. In G6PD deficiency uncontrolled oxidative stress causes hemoglobin to denature and form Heinz bodies. Bite cells result from the <strong>removal of Heinz bodies</strong> by macrophages in the spleen.</p>\n<p>Cotrimoxazole contains <strong>sulfamethoxazole</strong> which triggers a <strong>hemolytic reaction</strong> in persons with <strong>G6PD deficiency</strong>.</p>\n<p>Drugs that carry a risk of clinical hemolysis in persons with G6PD Deficiency:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Drugs</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Antimalarials</span></p>\n</td>\n<td>\n<ul>\n<li><span>Primaquine</span></li>\n<li><span><strong>Chloroquine</strong></span></li>\n<li><span>Dapsone/chlorproguanil</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Sulphonamides/</span></p>\n<p><span>sulphones</span></p>\n</td>\n<td>\n<ul>\n<li><span><strong>Sulfamethoxazole</strong></span></li>\n<li><span>Sulfasalazine</span></li>\n<li><span>Sulfisoxazole</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Antibacterial/</span></p>\n<p><span>antibiotics</span></p>\n</td>\n<td>\n<ul>\n<li><span><strong>Cotrimoxazole</strong></span></li>\n<li><span>Ciprofloxacin</span></li>\n<li><span>Chloramphenicol</span></li>\n<li><span>Nalidixic acid</span></li>\n<li><span>Norfloxacin</span></li>\n<li><span><strong>Nitrofurantoin</strong></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Others</span></p>\n</td>\n<td>\n<ul>\n<li><span>Naphthalene</span></li>\n<li><span><strong>Methylene blue</strong></span></li>\n<li><span>Rasburicase </span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/349620e0e0954b4f9f57bb5b46e9dcf6.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1277",
      "difficulty": "easy"
    },
    {
      "text": "All of the following are the products obtained in the uronic acid pathway in humans, except:",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin C"
        },
        {
          "id": 2,
          "text": "Glucuronic acid"
        },
        {
          "id": 3,
          "text": "Pentose sugars"
        },
        {
          "id": 4,
          "text": "Proteoglycans"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Vitamin C</strong> is not a product of the <strong>uronic</strong> acid pathway in humans.</p>\n<p>Glucuronic acid, pentose sugars, proteoglycans are all the products obtained in the uronic acid pathway in humans.</p>\n<p>In the liver, the <strong>uronic acid pathway </strong>is the <strong>source of glucuronic acid</strong> for conjugation of many endogenous and exogenous substances before excretion as glucuronides in urine and bile.</p>\n<p>The <strong>lack of</strong> one enzyme of the uronic acid pathway called <strong>L-gulonolactone oxidase</strong> in primates and some other animals including human beings explains why ascorbic acid (vitamin C) cannot be endogenously synthesized. Hence, it is a dietary requirement for human beings.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1872",
      "difficulty": "medium"
    },
    {
      "text": "A 28-year-old woman was found to have excessive urinary glucose levels. However, her blood glucose levels were normal. Further investigations revealed high levels of only L-xylulose in the urine. A genetic defect in which of the following pathways is most likely?",
      "choices": [
        {
          "id": 1,
          "text": "Krebs cycle"
        },
        {
          "id": 2,
          "text": "Uronic acid pathway"
        },
        {
          "id": 3,
          "text": "Ketone synthesis"
        },
        {
          "id": 4,
          "text": "HMP Shunt"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>High</strong> levels of <strong>L-xylulose</strong> in urine point to a diagnosis of <strong>essential pentosuria</strong>. It is a benign condition caused due to a defect in the <strong>uronic acid pathway.</strong></p>\n<p>Essential pentosuria has no clinical consequences. However, it can give <strong>false-positive</strong> results when urinary glucose is measured using alkaline copper reagents <strong>(Benedict’s test).</strong></p>\n<p>The lack of enzyme xylulose reductase of the uronic acid pathway leads to essential Pentosuria. Affected individuals excrete large amounts of L-xylulose in urine. Xylulose being a reducing sugar gives Benedict's test positive. <strong>Bial's test is positive</strong> as xylulose is a pentose.</p>\n<p>Essential pentosuria is a part of <strong>Garrod's tetrad</strong> which includes :</p>\n<ul>\n<li>Pentosuria</li>\n<li>Albinism</li>\n<li>Cystinuria</li>\n<li>Alkaptonuria</li>\n</ul><hr><h3>Related Pearl: Essential Pentosuria</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ccd1ed18d1004b4ea6d73d8d019c7d27x1280x1752.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1873",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the first enzyme to act on fructose metabolism?",
      "choices": [
        {
          "id": 1,
          "text": "Aldolase B"
        },
        {
          "id": 2,
          "text": "Fructokinase"
        },
        {
          "id": 3,
          "text": "Glucokinase"
        },
        {
          "id": 4,
          "text": "Hexokinase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Fructokinase</strong> is the first enzyme to act on fructose metabolism.</p>\n<p><strong>Fructokinase </strong>in the liver, kidneys and intestine catalyzes the phosphorylation of <strong>fructose</strong> <strong>to fructose-1-phosphate. </strong>This enzyme does not act on glucose and, unlike glucokinase, its activity is not affected by fasting or by insulin, which may explain why fructose is cleared from the blood of diabetic patients at a normal rate.</p>\n<p>Deficiency of fructokinase results in <strong>essential fructosuria</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/24fad35aebfb4f7dae8b9ec88ae936a5x1279x1703.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1875",
      "difficulty": "easy"
    },
    {
      "text": "A 10-month-old male baby is brought with vomiting, lethargy, and severe jaundice when weaning was started with fruit juice. Which of the following enzymes is most likely defective?",
      "choices": [
        {
          "id": 1,
          "text": "Aldolase A"
        },
        {
          "id": 2,
          "text": "Aldolase B"
        },
        {
          "id": 3,
          "text": "Fructokinase"
        },
        {
          "id": 4,
          "text": "Hexokinase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>hereditary fructose intolerance (HFI), </strong>which is due to <strong>deficiency</strong> of the enzyme<strong> aldolase</strong> <strong>B</strong>.</p>\n<p>Individuals affected with HFI are asymptomatic until they ingest fructose or sucrose (usually in the form of fruit, fruit juice, or sweetened cereal). Symptoms include:</p>\n<ul>\n<li>Hepatomegaly</li>\n<li>Jaundice</li>\n<li>Vomiting</li>\n<li>Lethargy</li>\n<li>Convulsions</li>\n<li>Hypoglycemia</li>\n</ul>\n<p>Urine-reducing sugar (<strong>Benedict's test</strong>) and tests for ketoses (<strong>Rapid Furfural and Seliwanoff's test</strong>) are positive. Treatment is the removal of fructose and sucrose from the diet.</p>\n<p>The flowchart given below depicts fructose metabolism. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aa3bd45895b441c1a1162d34a76543aax1280x1831.JPEG\" alt=\"Explanation Image\"><p>Other options: </p>\n<p>Option A: A deficiency of <strong>aldolase</strong> <strong>A</strong> leads to myopathy and hemolytic anemia.</p>\n<p>Option C: <strong>Fructokinase</strong> deficiency leads to essential fructosuria, which is a benign condition and does not have significant clinical manifestations. </p>\n<p>Option D: <strong>Hexokinase</strong> deficiency is a rare mutation that can present with hemolytic anemia and does not present with the symptoms in this patient. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1876",
      "difficulty": "easy"
    },
    {
      "text": "A patient was incidentally found to have essential fructosuria. Which of the following enzymes is deficient in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Aldolase A"
        },
        {
          "id": 2,
          "text": "Aldolase B"
        },
        {
          "id": 3,
          "text": "Fructokinase"
        },
        {
          "id": 4,
          "text": "Hexokinase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Essential fructosuria</strong> is due to the <strong>deficiency</strong> of the enzyme <strong>hepatic</strong> <strong>fructokinase. </strong>It is inherited in an <strong>autosomal recessive</strong> pattern.</p>\n<p>This defective degradation does not cause any clinical symptoms. Fructose is either excreted unchanged in the urine or metabolized to fructose-6-phosphate by alternate pathways in the body, most commonly by hexokinase in adipose tissue and muscle.</p>\n<p>No treatment is indicated for essential fructosuria.</p>\n<p>The flowchart given below depicts fructose metabolism.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c2dfed0a7f124e1aaab26d2a92115564x1280x1831.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1878",
      "difficulty": "easy"
    },
    {
      "text": "A newborn baby refuses breast milk since the 2nd day of birth but accepts glucose water. He develops vomiting and severe jaundice by the 5th day. Benedict's test was positive for urine and blood glucose was low. The most likely cause is due to the deficiency of",
      "choices": [
        {
          "id": 1,
          "text": "Aldose reductase"
        },
        {
          "id": 2,
          "text": "Galactokinase"
        },
        {
          "id": 3,
          "text": "Galactose-1-phosphate uridyl transferase"
        },
        {
          "id": 4,
          "text": "UDP galactose-4-epimerase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical features on ingestion of breastmilk at birth suggest <strong>classical galactosemia, </strong>a disorder of galactose metabolism. <strong>Galactose-1-phosphate uridyl transferase deficiency </strong>leads to <strong>classical galactosemia. </strong></p>\n<p>It is an<strong> </strong>autosomal recessive disorder. Clinical features include:</p>\n<ul>\n<li>Accumulation of galactose-1-phosphate in the liver causes liver damage &amp; leads to hepatomegaly, vomiting, convulsions.</li>\n<li>Accumulation of galactose-1-phosphate depletes the liver of inorganic phosphate leading to diminished ATP synthesis which affects gluconeogenesis resulting in hypoglycemia.</li>\n<li>Accumulation of galactose-1-phosphate in the nerves causes intellectual disability.</li>\n<li>Accumulation of <strong>galactitol</strong> in the lens causes an <strong>oil-drop cataract.</strong></li>\n</ul>\n<p>Urinary reducing sugar (<strong>Benedict's test)</strong> and the <strong>Mucic acid test</strong> are positive.</p>\n<p>Treatment is a galactose-free diet.</p>\n<p>The flowchart given below depicts galactose metabolism. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/273ae933e27941edbdbe9e4f99d5dbe6x1280x1129.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1879",
      "difficulty": "medium"
    }
  ]
}